Professor Maduike Ezeibe who laid claims to the discovery of a cure for HIV/ AIDS a fortnight ago has urged the National Agency for the Control of AIDS, NACA, to remain neutral and subject his claims to test if in doubt.
Speaking in an interview with Thisage yesterday, Ezeibe, a professor of Veterinary Medicine and Clinical Virology at the Michael Okpara University of Agriculture, Abia State stated that he was taken aback when he heard that the federal agency disparaged his claims without attempting to see him.
He said: “It is untrue that I have not contacted my peers in the profession or published my findings in peer review journals. I have over 10 publications on it.
“In May 2015, I attended the World Virological Conference in Atlanta, U.S.A where this discovery was announced. In another World Conference on Pharmacognosy and Pharmacology held the same year in Texas, U.S.A, I could not attend because I could not source the airfare, but I eventually did through a video conferencing. If Nigeria does not want to support me, well”.
Reacting to Ezeibe claims, which went viral on social media after press reports, that “Aluminium Magnesium Silicate was tested on 10 persons living with HIV and the clinical outcome made HIV a conquered organism”, the NACA boss , Dr. Sani Aliu dismissed the report outright.
According to him, “the claim for HIV/AIDS cure is not new. It is also not new to find a scientist using ambiguous scientific methods and practices to buttress this claim and to find obscure journals increasingly prepared to published these claims.”
Thisage has learned that some world acclaimed scientific research journals have published Ezeibe’s findings.
One is the World Journal of AIDS of June 2015, vol. 5, pgs 59-65, which published the findings under the title In Vitro Antiretroviral Effects of the Medicinal Synthetic Aluminum-Magnesium Silicate. There it is stated that patients were treated for between 4 and 12 weeks with one for 24 weeks and all had no adverse drug reactions.
Another publication is the British Journal of Medicine and Medical Research, 2014, where it was concluded that “the AMS has antiretroviral effects and could be an inexpensive antiretroviral therapy for regular treatment to reduce high rate of HIV infection among low income groups.”
On NACA’s Aliu calim that there was no evidence that he followed standard ethical protocols for clinical trials and obtained ethical clearance from an appropriate body in Nigeria, Ezeibe is calm.
He said: “ I call on the Minister of Health to tell agencies under his ministry to leave ethics (law) to lawyers so that we focus on medical sciences. What ethics is all about is to ensure patients get the best treatment possible. So, let them review the invention so that if it is better than what is being used, we change.
“I hereby call on the government to take over the clinical trial so that all the ethics can be followed. If then the result is as reported we can move forward.”